Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 107 Specimen Handling 89 pembrolizumab 82 enzalutamide 65 Nivolumab 64 Gemcitabine 59 Docetaxel 51 Abiraterone Acetate 44 apalutamide 43 Radiosurgery 43 Androgen Antagonists 43 Prednisone 42 darolutamide 40 Cisplatin 38 Biopsy 38 cabozantinib 34 Radiotherapy 34 Carboplatin 30 abiraterone 29 Pluvicto 29 Ipilimumab 29 durvalumab 25 enfortumab vedotin 24 Leuprolide 24 X-Rays 23 Radiation 23 atezolizumab 22 olaparib 20 Standard of Care 20 avelumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Self-Management × Genitourinary × 90 days × Clear all

NCT07264088 2026-04-16

FOLLOW-UP

Imperial College London

Not yet recruiting

100,000 enrolled

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡